BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2025

Rhea-AI Summary

BD (NYSE: BDX) said management will host an audio webcast at 8:00 a.m. ET on Thursday, November 6, 2025 to discuss fourth-quarter and full-year fiscal 2025 results (fiscal year ended September 30, 2025) and provide an operations and strategy update.

The company will issue a news release and presentation materials with summary financial information prior to the call. The live webcast and a replay will be available at www.bd.com/investors.

FRANKLIN LAKES, N.J., Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, November 6, 2025 to discuss the Company's financial results for its fourth quarter and full year of fiscal 2025, which ended on September 30, 2025, and to provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors, and a replay will be made available shortly after the call at the same website. Prior to the call, the Company will issue a news release and related presentation materials that will include summary financial information for the quarter. The news release and related presentation materials will be made available at www.bd.com/investors.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. 

Contacts:
Media:	Investors:
Fallon McLoughlin	Adam Reiffe
Director, Public Relations	Vice President, Investor Relations
201.258.0361	201.847.6927
fallon.mcloughlin@bd.com	adam.reiffe@bd.com

 

View original content:https://www.prnewswire.com/news-releases/bd-to-announce-financial-results-for-its-fourth-quarter-and-full-year-of-fiscal-2025-302580188.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

When will BD (BDX) report its fiscal 2025 Q4 and full-year results?

BD will discuss fiscal Q4 and full-year 2025 results on November 6, 2025 at 8:00 a.m. ET.

How can investors join the BD (BDX) financial results webcast on November 6, 2025?

Join the audio webcast via BD's investor site at www.bd.com/investors.

Will BD (BDX) publish materials before the November 6, 2025 call?

Yes. A news release and related presentation materials with summary financial information will be posted prior to the call on www.bd.com/investors.

Is a replay of BD's (BDX) November 6, 2025 earnings webcast available?

Yes. A replay will be made available shortly after the call at www.bd.com/investors.

What period do BD's (BDX) fiscal 2025 fourth-quarter results cover?

The fiscal 2025 year ended on September 30, 2025, and the Q4 results cover the quarter ending on that date.